Evidence map›Paper›PMID 22674013›Full record

ArticleEuropean journal of immunology2012

The reversible formation of cysteine sulfenic acid promotes B-cell activation and proliferation.

Katie E Crump, Daniel G Juneau, Leslie B Poole, Karen M Haas, Jason M Grayson

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Balanced Duality: HInternational journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. ROLE OF THIOLS IN OXIDATIVE STRESS.Current opinion in toxicology · 2018
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Katie E CrumpDepartment of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Daniel G Juneau
Leslie B Poole
Karen M Haas
Jason M Grayson
Wake Forest University · US

Funding

TRAINING PROGRAM IN IMMUNOLOGY AND PATHOGENESIST32AI007401 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Martha Ann Alexander-Miller · 1991 to 2026
$4.4M
Redox control of CD8 T cell proliferation, differentiation and deathR01AI068952 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GRAYSON, JASON MITCHELL · 2008 to 2012
$1.6M
Proteomic Profiling of Cancer-Related Redox Signaling PathwaysR33CA126659 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI POOLE, LESLIE B · 2008 to 2010
$948k
Mechanisms of CD8+ T Cell Apoptosis During Acute and Chronic Viral InfectionsR56AI073571 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GRAYSON, JASON MITCHELL · 2010 to 2010
$370k
NCI NIH HHS R33 CA126659NIAID NIH HHS 5T32AI007401-20NIAID NIH HHS R01 AI068952NIAID NIH HHS R01-AI068952NIAID NIH HHS R56 AI073571NIAID NIH HHS R56-AI073571NIAID NIH HHS T32 AI007401
6 · The paper itself

Abstract

B-cell receptor (BCR) ligation generates reactive oxygen intermediates (ROIs) that play a role in cellular responses. Although ROIs can oxidize all macromolecules, it was unclear which modifications control B-cell responses. In this study, we demonstrate the importance of the first oxidation product of cysteine, sulfenic acid, and its reversible formation in B-cell activation. Upon BCR crosslinking, B cells increase ROI levels with maximal production occurring within 15 min. Increased ROIs preceded elevated cysteine sulfenic acid, which localized to the cytoplasm and nucleus. Analysis of individual proteins revealed that the protein tyrosine phosphatases (PTPs) SHP-1, SHP-2, and PTEN, as well as actin, were modified to sulfenic acid following BCR ligation. Additionally, we used 5,5-dimethyl-1,3-cyclohexanedione (dimedone), a compound that covalently reacts with sulfenic acid to prevent its further oxidation or reduction, to determine the role of reversible cysteine sulfenic acid formation in regulating B-cell responses. Dimedone incubation resulted in a concentration-dependent block in anti-IgM-induced cell division, accompanied by a failure to induce capacitative calcium entry (CCE), and maintain tyrosine phosphorylation. These studies illustrate that reversible cysteine sulfenic acid formation is a mechanism by which B cells modulate pathways critical for activation and proliferation.

Indexed as

Lymphocyte ActivationActinsAnimalsBiological TransportB-LymphocytesCell DivisionCell ProliferationCyclohexanonesCysteineMicePhosphorylationProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine Phosphatase, Non-Receptor Type 6PTEN PhosphohydrolaseReactive Oxygen SpeciesReceptors, Antigen, B-CellActinsCyclohexanonesCysteinecysteine sulfinic aciddimedoneProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine Phosphatase, Non-Receptor Type 6PTEN PhosphohydrolasePten protein, mousePtpn11 protein, mousePtpn6 protein, mouseReactive Oxygen SpeciesReceptors, Antigen, B-Cell

Identifiers

PMID22674013
PMCPMC3659792
OpenAlexW2107185761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.